(2S,3S,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid

(2S,3S,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid

130676-66-3

C₂₉H₅₅NO₆

CCCCCCCCCCC[C@@H](C[C@H](O)[C@H](CCCCCC)C(O)=O)OC(=O)C(CC(C)C)NC=O

(2s,3s,5s)-5-[(n-formyl-l-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid ; orlistat impurity m1 ; n-formyl-l-leucine (1s)-1-[(2s,3s)-3-carboxy-2-hydroxynonyl]dodecyl ester ; orlistat open ring impurity (2s,3s,5s)-isomer ; [2r-[1(s*),2r*,3s*]]- n-formyl-l-leucine 1-[3-carboxy-2-hydroxynonyl]dodecyl ester ; (2s,3s,5s)-5-[(n-formyl-l-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid (orlistat impurity) ; (s)-3-hexyl-5,6-dihydro-6-undecyl-2h-pyran-2-one